Soleno Therapeutics
SLNO
SLNO
114 hedge funds and large institutions have $1.79B invested in Soleno Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 98 → 114 (+16)
11% more ownership
Funds ownership: 109.48% → 120.48% (+11%)
87% less call options, than puts
Call options by funds: $2.09M | Put options by funds: $15.7M
Holders
114
Holding in Top 10
10
Calls
$2.09M
Puts
$15.7M
Top Buyers
| 1 | +$62.7M | |
| 2 | +$51.2M | |
| 3 | +$37.2M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$29.8M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$27.4M |
Top Sellers
| 1 | -$44.9M | |
| 2 | -$12.6M | |
| 3 | -$7.54M | |
| 4 |
SC
Stempoint Capital
New York
|
-$4.96M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.89M |